已收盘 11-13 16:00:00 美东时间
+0.170
+1.30%
As October begins, investors are keeping a close eye on heavily shorted stocks that could see heightened volatility. The latest mid- to mega-cap screen shows 39 stocks with short interest above 20% of...
10-05 21:35
Samsara (IOT) was in focus on Monday as Jefferies started coverage on the tech firm with a Buy rating and a $50 price target. Shares were little changed in premarket trading. "IOT serves as a system o...
10-05 19:48
UiPath, Inc. (NYSE:PATH) shares are up by about half a percent during Wednesday’s premarket session. On Tuesday, the company expanded its partnership with BDO USA to develop AI and business orchestration solutions for key enterprise functions. It includes risk management, controls transformation, en...
09-30 19:47
今日重点评级关注:HC Wainwright & Co.:维持NeuroSense Therapeutics"买入"评级,目标价从8美元升至52美元;HC Wainwright & Co.:维持艾切托"买入"评级,目标价从27美元升至34美元
09-29 08:33
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Deutsche Bank analyst Steve Powers downgraded PepsiCo Inc (NASDAQ:PEP) from Buy to Hold and cut t...
09-29 01:47
UiPath Inc. (NYSE:PATH) stock fell on Monday after DA Davidson downgraded the company to Underperform and set a $10 price target. The downgrade follows several price forecast cuts from Wall Street brokerages since the company’s Investor Day on Sept. 22. The Nasdaq is down 1.18% while the S&P 500 has...
09-28 23:58
今日重点评级关注:古根海姆:维持Damora Therapeutics"买入"评级,目标价从40美元升至60美元;HC Wainwright & Co.:维持Rezolute"买入"评级,目标价从5美元升至10美元
09-28 12:37
今日重点评级关注:Canaccord Genuity:维持Aurora Innovation"买入"评级,目标价从15美元升至17美元;摩根大通:维持皇家加勒比邮轮"超配"评级,目标价从345美元升至394美元
09-25 15:55
今日重点评级关注:Leerink Partners:维持塞德斯医疗"跑赢大市"评级,目标价从70美元升至88美元;HC Wainwright & Co.:维持TriSalus Life Sciences"买入"评级,目标价从11美元升至12美元
09-24 16:10
UiPath Inc (NYSE:PATH) came under pressure on Wednesday, following the start of the company’s three-day flagship conference, Fusion 2026. The Analyst Day on Tuesday highlighted the company’s expanding AI opportunity, according to Needham. • UiPath stock is holding steady today. What’s ahead for PATH...
09-24 00:46